Sartorius first-quarter earnings substantially improved over the year-earlier quarter
In fiscal 2004, first-quarter sales revenue for the Sartorius Group rose 1.0% to EUR108.1 million from EUR107.0 million reported for the year-earlier period. Currency-adjusted consolidated sales revenue grew 5.4% to EUR112.8 million. The Biotechnology Division posted sales revenue growth of 3.5% to EUR54.6 million (year-earlier period: EUR52.8 million; currency-adjusted, 8.2%). First-quarter sales revenue for the Mechatronics Division slid 1.3% to EUR53.5 million (previous year: EUR54.2 million; currency-adjusted, +2.7%).
Concerning order intake, the Sartorius Group posted a first-quarter decline of 1.7% to EUR113.4 million from EUR115.4 million a year earlier, which was due to the impact of foreign exchange rates (currency-adjusted order intake: +4.9%). For the Biotechnology Division, order intake fell from EUR59.9 million to EUR54.9 million (-8.4%). Order intake for the Mechatronics Division rose 5.5% to EUR58.6 million (previous year: EUR55.5 million).
Net cash flow at EUR4.1 million continues to be positive (previous year: EUR6.9 million). In the period ended March 31, 2004, net debt shrank by EUR2.7 million to EUR102.3 million compared with the period ended December 31, 2003.
Most read news
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.